Cover Image

Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma

Nivolumab is a programmed death receptor 1 (PD-1) inhibitor. It is part of a group of drugs known as immune checkpoint blockers, which enable potent and durable T-cell responses against several tumors. We report the case of a patient with a metastatic squamous cell carcinoma, who is being treated wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Marcos Oro-Ayude (Author), Hae Jin Suh-Oh (Author), Victor Sacristán-Santos (Author), Patricia Vázquez-Bartolomé (Author), Ángeles Flórez (Author)
Format: Book
Published: Karger Publishers, 2020-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items